CA
TYRA icon

Clearstead Advisors’s Tyra Biosciences TYRA Stock Holding History

Clearstead Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$921 Hold
29
– – ﹤0.01% 2723
2026
Q1 		$1.1K Hold
29
– – ﹤0.01% 2026
2025
Q4 		$759 Sell
29
-96
-77% -$1.76K ﹤0.01% 2260
2025
Q3 		$1.75K Hold
125
– – ﹤0.01% 2484
2025
Q2 		$1.2K Buy
+125
New +$1.19K ﹤0.01% 2411

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Clearstead Advisors's TYRA Position: Q2 2026 in Review

Clearstead Advisors held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 29 shares worth $921. The position accounts for ﹤0.01% of the portfolio, ranked #2723.

Clearstead Advisors first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.75K in Q3 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Clearstead Advisors held 29 shares of Tyra Biosciences worth $921 as of Q2 2026.
  • Clearstead Advisors left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2723 holding.
  • Clearstead Advisors first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Clearstead Advisors's Tyra Biosciences position peaked at $1.75K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.